Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 7, 2016Cancer ResearchOpen Access

Lenalidomide Stabilizes the Erythropoietin Receptor by Inhibiting the E3 Ubiquitin Ligase RNF41

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAshley A. BasiorkaKMKathy L. McGrawLCLeentje De Ceuninck

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Basiorka et al. (2016) studied this question.

synapsesocial.com/papers/6a895e5d1fb56efa37d44807https://doi.org/10.1158/0008-5472.can-15-1756
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Toll-like Receptor-4 Is Up-Regulated in Hematopoietic Progenitor Cells and Contributes to Increased Apoptosis in Myelodysplastic Syndromes2007 · 137 citations
  2. 2Bortezomib interferes with C-KIT processing and transforms the t(8;21)-generated fusion proteins into tumor-suppressing fragments in leukemia cells2012 · 34 citations
  3. 3Lenalidomide — The Phoenix Rises2007 · 34 citations
  4. 4Lenalidomide: Targeted Anemia Therapy for Myelodysplastic Syndromes2006 · 43 citations
  5. 5RNF41 (Nrdp1) controls type 1 cytokine receptor degradation and ectodomain shedding2011 · 64 citations